AN2 Therapeutics, Inc.ANTXNASDAQ
LOADING
|||
Switch Symbol:
Cash Flow Performance
Trending lower, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-119.66%
↓ 339% below average
Average (5y)
-27.23%
Historical baseline
Range
High:-0.86%
Low:-119.66%
CAGR
+168.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -119.66% | -985.9% |
| 2023 | -11.02% | +51.9% |
| 2022 | -22.89% | -222.5% |
| 2021 | -7.10% | -281.9% |
| 2020 | -1.86% | -115.8% |
| 2019 | -0.86% | - |